Home›People›Diane Jorkasky, M.D.
Diane Jorkasky, M.D.

Diane Jorkasky, M.D.

Director at Alzheon.

Director
Updated Nov 9, 2026·Latest SEC filing Sep 10, 2026·Suggest an edit

About Diane Jorkasky, M.D.

Diane Jorkasky, M.D. is a director at Alzheon.

Diane Jorkasky, M.D. first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Diane Jorkasky, M.D. in the role, so the role may have started earlier or lasted longer.

Alzheon, Inc.
Director
2020 – 2026 · Framingham, MA
Develops investigational medicines for people with Alzheimer’s and other neurodegenerative disorders.

Key Colleagues at Startups

The people Diane Jorkasky, M.D. works with at each company, as listed on that company's latest Form D.

Alzheon, Inc. · Form D, Sep 10, 2026
Neil Flanzraich
Neil Flanzraich
Executive Chairman of the Board of Directors
JD
John Hey, Ph.D.
Chief Scientific Officer
SD
Susan Abushakra, M.D.
Chief Medical Officer
MS
AM
Aidan Power, MRCPsych
Chief Development Officer
Gino Santini
Gino Santini
Director
Kenneth Mace
Kenneth Mace
Chief Financial Officer
MD
Martin Tolar, M.D., Ph.D.
Founder, President & CEO, director
Adem Albayrak
Adem Albayrak
Chief Data & AI Officer

Sources

  1. SECAlzheon, Inc. Form D, filed Sep 10, 2026